Physician profile
Devon Amanda Abele
NPI 1255817672
$4,113.60
in general payments reported to CMS, 2019-2025
11 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $563 · 2022: $496 · 2023: $1,315 · 2024: $1,121 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,054.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,710.26 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Zoom Wireless Transmitter |
| Janssen Pharmaceuticals, INC | $901.98 | 2021-2024 | Xarelto |
| Biotronik INC. | $354.27 | 2024-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $300.40 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $227.19 | 2023 | Stelara |
| Medtronic, INC. | $217.25 | 2023-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Kestra Medical Technology Services, INC. | $170.08 | 2024 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.78 | 2021-2024 | Jardiance |
| Abbott Laboratories | $64.34 | 2024-2025 | Aveir, Assurity, Amplatzer Amulet |
| Pfizer INC. | $62.66 | 2022-2025 | |
| Biosense Webster, INC. | $29.39 | 2023 | Qdot Micro Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Abele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.